OCUP: Opus Genetics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 53.22
Enterprise Value ($M) 41.74
Book Value ($M) 25.57
Book Value / Share 0.56
Price / Book 2.08
NCAV ($M) 25.32
NCAV / Share 0.56
Price / NCAV 2.10

Profitability (mra)
Return on Invested Capital (ROIC) -2.25
Return on Assets (ROA) -1.11
Return on Equity (ROE) -1.25

Liquidity (mrq)
Quick Ratio 3.24
Current Ratio 3.24

Balance Sheet (mrq) ($M)
Current Assets 36.61
Assets 36.86
Liabilities 11.29
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 10.99
Operating Income -34.07
Net Income -57.53
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -25.58
Cash from Investing 1.21
Cash from Financing 4.19

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2024 ☐ TRANSITION REPORT PURS

(click for more detail)

Similar Companies
ABEO – Abeona Therapeutics Inc. ABVC – ABVC BioPharma, Inc.
ACB – Aurora Cannabis Inc. ACHV – Achieve Life Sciences, Inc.
ACXP – Acurx Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io